Because our medicines, intended for critical medical situations, contribute to better patient management, for more than a hundred years AGUETTANT has been committed to providing support for healthcare professionals by offering innovative injectable products, to meet their needs in terms of reliability and safety of administration:

  • Injectable medicines ready-to-use in pre-filed syringe with a high medical value,
  • Medicines which play an essential role in therapeutic strategies,
This expertise underlies our mission as a pharmaceutical company:
to develop, produce and market essential medicines.

1880 Founding of the company “TAVERNIER & AGUETTANT” in Lyon,
1903 Injectable products were established as AGUETTANT’s core business.
1914 AGUETTANT has specialised in the development and manufacture of essential injectable products for hospital settings.
1942 Operations moved away from the dispensary and industrial production started.
1961 The only pharmaceutical company in France to offer solutions in flexible containers.
1971 First pharmaceutical company in Europe to be equipped with a continuous steriliser.
1987 Opening of the Champagne production site.
1996 Launch into the European market of the first pump fitted with a programmable timer.
1999 Launch of the auto-injector pen pre-filled with apomorphine.
2007 Construction of a new distribution facility in the Rhône region, sized for worldwide operations.
2009 Launch of the ready-to-use pre-filled plastic syringe in Europe.
2014 Construction of a new production site at Lyon Gerland to meet the requirements of international benchmarks.